Human chimeric antigen receptor macrophages for cancer immunotherapy
Top Cited Papers
- 23 March 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature Biotechnology
- Vol. 38 (8), 947-953
- https://doi.org/10.1038/s41587-020-0462-y
Abstract
Chimeric antigen receptor (CAR) T cell therapy has shown promise in hematologic malignancies, but its application to solid tumors has been challenging1,2,3,4. Given the unique effector functions of macrophages and their capacity to penetrate tumors5, we genetically engineered human macrophages with CARs to direct their phagocytic activity against tumors. We found that a chimeric adenoviral vector overcame the inherent resistance of primary human macrophages to genetic manipulation and imparted a sustained pro-inflammatory (M1) phenotype. CAR macrophages (CAR-Ms) demonstrated antigen-specific phagocytosis and tumor clearance in vitro. In two solid tumor xenograft mouse models, a single infusion of human CAR-Ms decreased tumor burden and prolonged overall survival. Characterization of CAR-M activity showed that CAR-Ms expressed pro-inflammatory cytokines and chemokines, converted bystander M2 macrophages to M1, upregulated antigen presentation machinery, recruited and presented antigen to T cells and resisted the effects of immunosuppressive cytokines. In humanized mouse models, CAR-Ms were further shown to induce a pro-inflammatory tumor microenvironment and boost anti-tumor T cell activity.Funding Information
- Penn | Perelman School of Medicine at the University of Pennsylvania | Abramson Family Cancer Research Institute
- Carisma Therapeutics Inc. [Sponsored Research Agreement]
This publication has 38 references indexed in Scilit:
- Prognostic Significance of Tumor-Associated Macrophages in Solid Tumor: A Meta-Analysis of the LiteraturePLOS ONE, 2012
- The presence of tumor associated macrophages in tumor stroma as a prognostic marker for breast cancer patientsBMC Cancer, 2012
- Human Macrophages and Dendritic Cells Can Equally Present MART-1 Antigen to CD8+ T Cells after Phagocytosis of Gamma-Irradiated Melanoma CellsPLOS ONE, 2012
- AML xenograft efficiency is significantly improved in NOD/SCID-IL2RG mice constitutively expressing human SCF, GM-CSF and IL-3Leukemia, 2010
- The application of adjuvant autologous antravesical macrophage cell therapy vs. BCG in non-muscle invasive bladder cancer: a multicenter, randomized trialJournal of Translational Medicine, 2010
- Exploring the full spectrum of macrophage activationNature Reviews Immunology, 2008
- The inflammasome recognizes cytosolic microbial and host DNA and triggers an innate immune responseNature, 2008
- Development of an adenoviral vector system with adenovirus serotype 35 tropism; efficient transient gene transfer into primary malignant hematopoietic cellsThe Journal of Gene Medicine, 2004
- CD46 is a cellular receptor for group B adenovirusesNature Medicine, 2003
- Adoptive Immunotherapy For Superficial Bladder Cancer With Autologous Macrophage Activated Killer CellsJournal of Urology, 2002